We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$853M
AUM Growth
-$19.3M
Cap. Flow
-$81.6M
Cap. Flow %
-9.56%
Top 10 Hldgs %
13.72%
Holding
1,104
New
422
Increased
110
Reduced
108
Closed
462

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$14M
2
NKE icon
Nike
NKE
+$11.7M
3
MDB icon
MongoDB
MDB
+$9.23M
4
TXN icon
Texas Instruments
TXN
+$8M
5
FTNT icon
Fortinet
FTNT
+$7.77M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$39.5M
2
ACN icon
Accenture
ACN
+$13.2M
3
ULTA icon
Ulta Beauty
ULTA
+$11.4M
4
ADBE icon
Adobe
ADBE
+$11.3M
5
TSLA icon
Tesla
TSLA
+$9.53M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Consumer Discretionary 16.21%
3 Healthcare 10.72%
4 Industrials 10.26%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPEL icon
401
XPEL
XPEL
$1.4B
$438K 0.05%
+10,100
New +$407K
PECO icon
402
Phillips Edison & Co
PECO
$5.05B
$437K 0.05%
+11,600
New +$414K
RRX icon
403
Regal Rexnord
RRX
$10.9B
$435K 0.05%
+2,622
New +$405K
BOOT icon
404
Boot Barn
BOOT
$4.71B
$435K 0.05%
+2,600
New +$358K
ADNT icon
405
Adient
ADNT
$1.45B
$434K 0.05%
+19,245
New +$440K
SLAB icon
406
Silicon Laboratories
SLAB
$7.31B
$434K 0.05%
+3,753
New +$419K
RVNC
407
DELISTED
Revance Therapeutics, Inc.
RVNC
$433K 0.05%
+83,500
New +$415K
CP icon
408
Canadian Pacific Kansas City
CP
$82.5B
$429K 0.05%
+5,021
New +$413K
TBBK icon
409
The Bancorp
TBBK
$2.71B
$425K 0.05%
7,952
+1,452
+22% +$70.2K
EOSE icon
410
Eos Energy Enterprises
EOSE
$1.25B
$423K 0.05%
+142,400
New +$301K
SYNA icon
411
Synaptics
SYNA
$3.82B
$423K 0.05%
+5,446
New +$437K
AAL icon
412
American Airlines Group
AAL
$9.08B
$419K 0.05%
+37,300
New +$395K
WDAY icon
413
Workday
WDAY
$47.8B
$416K 0.05%
+1,701
New +$402K
CRS icon
414
Carpenter Technology
CRS
$24.3B
$415K 0.05%
+2,600
New +$352K
CRSP icon
415
CRISPR Therapeutics
CRSP
$5.74B
$413K 0.05%
8,800
+2,600
+42% +$132K
PTEN icon
416
Patterson-UTI
PTEN
$4.68B
$412K 0.05%
+53,800
New +$496K
PPLI
417
People Inc
PPLI
$2.93B
$410K 0.05%
9,296
-4,876
-34% -$203K
PCRX icon
418
Pacira BioSciences
PCRX
$1.03B
$408K 0.05%
+27,080
New +$463K
SQM icon
419
Sociedad Química y Minera de Chile
SQM
$23B
$404K 0.05%
9,700
-26,800
-73% -$1.03M
IDYA icon
420
IDEAYA Biosciences
IDYA
$4.03B
$402K 0.05%
+12,686
New +$481K
ASB icon
421
Associated Banc-Corp
ASB
$5.82B
$402K 0.05%
+18,649
New +$405K
ZBH icon
422
Zimmer Biomet
ZBH
$19B
$400K 0.05%
+3,707
New +$405K
TVTX icon
423
Travere Therapeutics
TVTX
$6.36B
$398K 0.05%
+28,415
New +$296K
MRNA icon
424
Moderna
MRNA
$57B
$394K 0.05%
+5,900
New +$542K
SLM icon
425
SLM Corp
SLM
$5.03B
$393K 0.05%
+17,200
New +$371K

Similar funds

Bayesian Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Bayesian Capital Management held 1,104 positions worth $853M, down 2.2% from $873M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Bayesian Capital Management withdrew a net $81.6M in Q3 2024, closing 462 positions and reducing 108 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $39.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in MongoDB worth $9.61M.

  • Bayesian Capital Management's largest Q3 2024 buy was MongoDB: 35,529 shares worth $9.61M.
  • Bayesian Capital Management added most to Netflix in Q3 2024, an estimated $14M increase.
  • Bayesian Capital Management's biggest Q3 2024 reduction was Adobe, cutting an estimated $11.3M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $39.5M.
  • Bayesian Capital Management's ten largest holdings make up 14% of its $853M portfolio in Q3 2024.
  • Bayesian Capital Management opened 422 new positions and closed 462 in Q3 2024.
  • Bayesian Capital Management's portfolio value fell 2.2% quarter-over-quarter to $853M.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.